Q2 2024 Eckert & Ziegler SE Earnings Call Transcript

Author's Avatar
Aug 09, 2024

Aug 09, 2024 / NTS GMT
Harald Hasselmann - Eckert & Ziegler SE - Chairman of the Executive Board(CEO)Segment Medical

A big welcome to everybody. (Event Instructions)

I have the pleasure to lead you through the first half year of '24. My voice is a little off because I have a cold throat, but that shouldn't disturb us too much from presenting wonderful numbers which you have preliminary received a while ago when we had a talk was released in August. Now there's more precise data, I would like to share more in-depth details here with you for the last six months and also for the outer period this year. It will take some 20 slides. And then as usual, we will go through the list of questions. Whoever wants to join is very much invited.

Good, then let me see. There we go. This is the usual disclaimer as you know. Now the Board of the -- first off, the Executive Board hasn't changed. China is of highest importance, as you know, for our corporation, and Frank Yeager running the US business for the IP segment is also later on available via e-mail if you have any specific questions you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot